Laura Brege Net Worth & Insider Trades

Laura Brege - Director, Mirum Pharmaceuticals, Inc

As of June 6, 2022

What is Laura Brege's Net Worth?

The current estimated net worth of Mirum Pharmaceuticals, Inc's Director, Laura Brege, is estimated to be about $7.24M . Laura Brege owns about 10,000 units of Mirum Pharmaceuticals, Inc common stock. In the last 3 years at Mirum Pharmaceuticals, Inc, Laura Brege has sold an estimated value of $0 worth.

What is Laura Brege's Past Insider Trading?

Laura Brege's largest purchase order was 10,000 units , worth over $112.2K on September 12, 2019. In total, Laura Brege has made about 5 transactions over 3 years of their time at Mirum Pharmaceuticals, Inc. Laura Brege usually trades in June, with the busiest year in 2019.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Laura Brege's' Mailing Address?

  • Mailing address is C/o Onyx Pharmaceuticals, Inc. 2100 Powell Street Emeryville CA 94608 CA

Mirum Pharmaceuticals, Inc Executive Compensation

Name
Year
Salary
Bonus
Option Awards
Other Compensation
Total
Christopher Peetz 2020 $511,818 $265,952 $2,218,755 $7,453 $3,003,978
Christopher Peetz 2019 $457,614 $286,100 $5,491,471 - $6,235,185
Peter Radovich 2020 $277,992 $111,197 $2,255,631 - $2,644,820
Ian Clements, Ph.D. 2020 $378,390 $151,356 $848,348 $11,400 $1,389,494
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1759425/000119312521116249/d352758ddef14a.htm

What are Mirum Pharmaceuticals, Inc's Past Insider Trades?

Mirum Pharmaceuticals, Inc's most recent insider trade came on June 8, 2022 by James Flynn, Deerfield Mgmt Hif Lp, Deerfield Mgmt Iv Lp, Deerfield Management Company LP Series C, Deerfield Private Design Fund Iv Lp and Deerfield Healthcare Innovations Fund Lp who sold 38,478 units worth $962.26K . In the last 3 years, insiders at Mirum Pharmaceuticals, Inc have sold an estimated value of $3.82M and bought an estimated value of $113.81M worth of shares. Insider trading is most common in June, with the busiest year in 2021. The most active traders at the company are Ian Clements, Chief Financial Officer,  Jonathan Edwin Tucker, Chief Medical Officer,  and Christopher Peetz, President and CEO .

Mirum Pharmaceuticals, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1